Amgen

Amgen's Epogen: Can This Blockbuster Drug Keep Shining?
Motley Fool
Mon, 10/29/12 - 11:40 am
anemia
Amgen
Epogen
Amgen 3rd quarter profit higher, raises 2012 forecast
Reuters
Tue, 10/23/12 - 04:50 pm
Amgen
earnings
Amgen Earnings Sneak Peek
Wall Street Cheat Street
Sun, 10/21/12 - 10:52 am
Amgen
earnings
Amgen's Soaring, but Will Gravity Kick In?
Motley Fool
Sat, 10/20/12 - 10:26 am
Amgen
Amgen Third Quarter Earnings Sneak Peek
Wall St. Cheat Sheet
Thu, 10/18/12 - 01:06 pm
earnings
Amgen
Can Ampio's New Science Take A Big Bite Out Of The $60 Billion Anti-Inflammatory Market?
Seeking Alpha
Thu, 10/18/12 - 11:37 am
Ampio
Humira
Remicade
Enbrel
Celebrex
anti-inflammatories
Abbott Labs
Amgen
Ampion
JNJ
Pfizer
3 Things to Watch With Celldex Therapeutics
Motley Fool
Thu, 10/4/12 - 10:52 am
Celldex
rindopepimut
CDX-011
Pfizer
Bristol-Myers Squibb
Amgen
Seattle Genetics
Another Approval for Amgen's Prolia
Yahoo/Zacks
Tue, 09/25/12 - 04:45 pm
Amgen
Prolia
Merck
Eli Lilly
osteoporosis
Amgen Inc: Today's Featured Health Care Laggard
The Street
Sat, 09/15/12 - 09:29 am
Amgen
Amgen drops after analyst says sales of key drug may disappoint Street
Yahoo/The Fly On The Wall
Sat, 09/15/12 - 09:17 am
Amgen
Zalicus Misses Key Secondary Endpoint
Seeking Alpha
Mon, 09/10/12 - 01:40 pm
Zalicus
Amgen
Novartis
Sanofi
Synavive
rheumatoid arthritis
Amgen Joins Renault Selling Bonds to Pre-Empt Crisis Woes
Bloomberg
Mon, 09/10/12 - 10:49 am
Renault
Amgen
bonds
Why Analysts Love Teva
Seeking Alpha
Mon, 09/10/12 - 10:47 am
Amgen
JNJ
Teva Pharmaceuticals
Merck
Pfizer
Watson Pharmaceuticals
Amgen Inc: Today's Featured Drugs Laggard
The Street
Sat, 09/8/12 - 10:43 am
Amgen
Ampio's New Anti-Inflammatory Drug May Achieve Rapid FDA Clearance
Seeking Alpha
Wed, 09/5/12 - 06:53 pm
Ampio
FDA
Abbott Labs
JNJ
Amgen
Pfizer
Ampion
osteoarthritis
A Good Start on the Biosimilar Front
Motley Fool
Tue, 09/4/12 - 11:04 am
biosimilars
Teva Pharmaceuticals
Amgen
Watson Pharmaceuticals
Momenta
Baxter International
FDA
Affordable Care Act
2012 Biotech Stock Predictions: An Interim Report Card
TheStreet.com
Tue, 08/28/12 - 11:07 am
Cell Therapeutics
Momenta
Onyx
Amag Pharmaceuticals
Biomarin
M&A
Celgene
Seattle Genetics
Galena Biopharma
ImmunoCellular
Amgen
Celldex
Dendreon
GSK
Vical
Oncothyreon
Biogen Idec
Merck KGaA
Bristol-Myers Squibb
Allos
Spectrum Pharmaceuticals
AstraZeneca
Healthcare Sector Undervalued, 3 Stocks With Mixed Upside
Motley Fool
Sat, 08/25/12 - 11:32 am
Bristol-Myers Squibb
Amgen
Baxter
Amgen Doing Fine Despite Challenges
Investors.com
Wed, 08/22/12 - 11:04 am
Amgen
Amgen: When Buybacks Work
Seeking Alpha
Sun, 08/19/12 - 11:33 am
Amgen

Pages